Displaying 621 - 640 of 4770
FTC Sues to Block Merger Between New Jersey Healthcare Rivals RWJBarnabas Health and Saint Peter’s Healthcare System
Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson in the Matter of Buckeye Partners/Magellan Midstream Partners
FTC and Justice Department to Hold Two-Day Virtual Public Workshop Examining Antitrust Enforcement in the Pharmaceutical Industry
Federal Trade Commission Launches Inquiry into Infant Formula Crisis
Medtronic/Intersect ENT; Analysis of Agreement Containing Consent Orders To Aid Public Comment
FTC Chair Lina M. Khan Testifies Before House Appropriations Subcommittee
Written Submission on the Public Interest of Chair Lina M. Khan and Commissioner Rebecca Kelly Slaughter in the Matter of Certain UMTS and LTE Cellular Communication Modules
FTC Acts to Protect Patients Who Rely on Medical Instruments Used in Sinus Procedures
Hikma Pharmaceuticals PLC/Custopharm, Inc.; Analysis of Agreement Containing Consent Orders To Aid Public Comment
FTC Requires Prince and Ferro to Sell Off Three Facilities amid Concerns that Deal would Increase Concentration in North American Market for Porcelain Enamel Frit
Clarence L. Werner, U.S. v.
Clarence L. Werner, founder of the Omaha, Nebraska-based truckload carrier Werner Enterprises, Inc. will pay a $486,900 civil penalty to settle charges that certain of his acquisitions of company stock while he was a director of the company violated the Hart-Scott-Rodino Act. The HSR Act requires companies and individuals to report stock purchases over a certain threshold to the FTC and DOJ and wait before closing the transaction so that the federal agencies can investigate the potential competitive impact of the acquisition. Smaller transactions may also be reportable under the Act due to the need to aggregate the new purchase with all current holdings.
Federal Trade Commission Preserves Competition for Development and Marketing of Steroid Injectable Drug
Statement Regarding Texas Jury’s Verdict that Former Owner Neeraj Jindal Obstructed FTC’s Antitrust Investigation into Physical Therapy Staffing Company
Federal Trade Commission Extends Public Comment Period for Request for Information on Impact of Pharmacy Benefit Managers
FTC Approves Final Order Prohibiting Louisiana Real Estate Appraisers Board from Fixing Prices for Appraisal Services in Louisiana
Louisiana Real Estate Appraisers Board, In the Matter of
The Federal Trade Commission filed an administrative complaint against the Louisiana Real Estate Appraisers Board, alleging that the group is unreasonably restraining price competition for appraisal services in Louisiana, contrary to federal antitrust law. The complaint alleged that the appraisal board’s regulations exceeded the scope of the mandate outlined in the Dodd-Frank Act that required appraisal management companies to pay “a rate that is customary and reasonable for appraisal services performed in the market area of the property being appraised.” Specifically, the board required appraisal fees to equal or exceed the median fees identified in survey reports commissioned and published by the board. The board then investigated and sanctioned companies that paid fees below the specified levels.
Shortly before the administrative trial was set to begin, the FTC and the board reached a proposed settlement agreement.
On April 5, 2022, the Commission announced the final consent agreement in this matter.
EnCap/EP Energy; Analysis of Agreement Containing Consent Orders To Aid Public Comment
Displaying 621 - 640 of 4770